Aurora Cannabis urges shareholders to take no action as Curaleaf yet to file revised bid
Bitget2026/10/05 22:12Curaleaf plans to revise its bid for Aurora Cannabis, offering implied consideration of USD 5.00 per share. Revised terms: 0.4013 Curaleaf subordinate voting shares per Aurora share, with USD 1.00 cash per share. Aurora’s special committee has not received the revised filing, delaying a full evaluation and any formal board recommendation. Curaleaf indicated it will add pro forma financial statements and extend the offer expiry to Dec. 4, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610051811PR_NEWS_USPR_____TO64233) on October 05, 2026, and is solely responsible for the information contained therein.
- Curaleaf plans to revise its bid for Aurora Cannabis, offering implied consideration of USD 5.00 per share.
- Revised terms: 0.4013 Curaleaf subordinate voting shares per Aurora share, with USD 1.00 cash per share.
- Aurora’s special committee has not received the revised filing, delaying a full evaluation and any formal board recommendation.
- Curaleaf indicated it will add pro forma financial statements and extend the offer expiry to Dec. 4, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
The number of stablecoin holders on the Solana chain has surpassed 14 million.